Company intelligence / Profile preview

Keyto

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Keyto is a health technology company that developed a portable breath sensor and mobile application designed to help users track and maintain a ketogenic diet. The device measures breath acetone levels, a biomarker for ketosis, providing real-time feedback on fat burning. The company's platform combines hardware with a personalized coaching app to support weight loss and metabolic health. In 2022, Keyto was acquired by Levels, a metabolic health company, to integrate its breath-sensing technology and expertise into the Levels platform.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: DeviceDigital Health
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Keyto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keyto.

Explore the full profile